To expose or not to expose: A comprehensive perspective on treatment for posttraumatic stress disorder.


Journal

The American psychologist
ISSN: 1935-990X
Titre abrégé: Am Psychol
Pays: United States
ID NLM: 0370521

Informations de publication

Date de publication:
Apr 2024
Historique:
medline: 18 4 2024
pubmed: 18 4 2024
entrez: 18 4 2024
Statut: ppublish

Résumé

Trauma-focused psychotherapies, in particular prolonged exposure (PE) therapy, have been recognized as the "gold standard" for the treatment of posttraumatic stress disorder (PTSD). But effectiveness and implementation data show that a large proportion of patients who undergo exposure therapy retain their PTSD diagnosis, and implementation studies have shown low engagement and high dropout rates. Meanwhile, non-trauma-focused therapies have shown promise in treating PTSD. In this review, we aim to answer the question of whether exposure is necessary to treat PTSD by integrating clinical and research literature from multiple perspectives. We review the roots of exposure therapy in both psychodynamic and behavioral paradigms and their proposed mechanisms. We then review non-trauma-focused treatments and their proposed mechanisms. We conclude that the specific form of exposure required by PE is not necessary for symptom remission. Finally, common psychotherapy factors may facilitate patient self-directed exposure outside of the therapy context. These findings should alter the direction of clinical research to identify the therapy processes that most effectively promote the processing of trauma memories. With respect to clinical practice, shared decision-making should allow for increased patient autonomy in choosing either trauma-focused or non-trauma-focused treatments. (PsycInfo Database Record (c) 2024 APA, all rights reserved).

Identifiants

pubmed: 38635195
pii: 2024-73706-001
doi: 10.1037/amp0001121
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

331-343

Auteurs

Arielle Rubenstein (A)

Department of Psychiatry, Yale University School of Medicine.

Or Duek (O)

Department of Psychiatry, Yale University School of Medicine.

Jennifer Doran (J)

Department of Psychiatry, Yale University School of Medicine.

Ilan Harpaz-Rotem (I)

Department of Psychiatry, Yale University School of Medicine.

Classifications MeSH